Compound details
Nantoamide
| Compound ID | CDAMM00683 |
|---|---|
| Common name | Nantoamide | IUPAC name | N-(2-phenylethyl)-1,3-benzodioxole-5-carboxamide |
| Molecular formula | C16H15NO3 |
| Retention time | 7.68 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 292.095 | Theoretical mz | 292.094 |
| Error | 1.31 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.4655 |
| Inchi key | KBJGLIJMWJNSKP-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C(NCCC=1C=CC=CC1)C2=CC=C3OCOC3=C2 |
| Superclass | Organoheterocyclic compounds |
| Class | Benzodioxoles |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q9GZV3 | SLC5A7 | High-affinity choline transporter (by homology) | T83143 | SEA |
| P08912 | CHRM5 | Muscarinic acetylcholine receptor M5 | T79961 | SEA |
| P11229 | CHRM1 | Muscarinic acetylcholine receptor M1 | T28893 | SEA |
| P22303 | ACHE | Acetylcholinesterase | T30082 | SEA |
| P20309 | CHRM3 | Muscarinic acetylcholine receptor M3 | T67684 | SEA |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SEA |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction and SEA |
| P29475 | NOS1 | Nitric-oxide synthase, brain | T16117 | SwissTargetPrediction |
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SEA |
| P29474 | NOS3 | Nitric-oxide synthase, endothelial | T06046 | SwissTargetPrediction |
| Q07820 | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | T14912 | SEA |
| Q99720 | SIGMAR1 | Sigma opioid receptor | T46360 | SwissTargetPrediction and SEA |
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| Q96KS0 | EIT6 | HIF-prolyl hydroxylase 1 | T53904 | SEA |
| P15144 | ANPEP | Aminopeptidase N | T67272 | SEA |
| P00734 | F2 | Thrombin | T94033 | SwissTargetPrediction |
| O15379 | HDAC3 | Histone deacetylase 3 | T05090 | SEA |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SEA |
| P21397 | MAOA | Monoamine oxidase A | T83875 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction and SEA |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction and SEA |
| P16083 | NQO2 | Quinone reductase 2 | T75498 | SwissTargetPrediction and SEA |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SEA |
| Q9NTG7 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | T91959 | SwissTargetPrediction |
| Q8IXJ6 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | T83904 | SwissTargetPrediction |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P08514 | ITGA2B | Integrin alpha-IIb/beta-3 | T50688 | SEA |
| Q96RI1 | NR1H4 | Bile acid receptor FXR | T51426 | SEA |
| P08473 | MME | Neprilysin | T05409 | SEA |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P21554 | CNR1 | Cannabinoid receptor 1 (by homology) | T76685 | SwissTargetPrediction and SEA |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SEA |
| Q02083 | NAAA | N-acylsphingosine-amidohydrolase (by homology) | T78326 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction and SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SwissTargetPrediction and SEA |
| O60341 | KDM1A | Lysine-specific histone demethylase 1 | T16739 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction and SEA |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction and SEA |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SEA |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction and SEA |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SEA |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SEA |
| Q01959 | SLC6A3 | Dopamine transporter | T55959 | SwissTargetPrediction |
| P56524 | HDAC4 | Histone deacetylase 4 | T63816 | SEA |
| Q9UKV0 | HDAC9 | Histone deacetylase 9 | T03687 | SEA |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SEA |
| Q99705 | MCHR1 | Melanin-concentrating hormone receptor 1 | T09572 | SwissTargetPrediction and SEA |
| Q9H3R0 | KDM4C | Lysine-specific demethylase 4C | T73863 | SwissTargetPrediction |
| P23141 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | T76369 | SwissTargetPrediction and SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SwissTargetPrediction |
| O75164 | KDM4A | Lysine-specific demethylase 4A | T18904 | SwissTargetPrediction |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SwissTargetPrediction |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SEA |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SEA |
| P06401 | PGR | Progesterone receptor | T22939 | SwissTargetPrediction |
| P25021 | HRH2 | Histamine H2 receptor | T30985 | SEA |
| P08575 | PTPRC | Leukocyte common antigen | T43115 | SwissTargetPrediction and SEA |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | T21307 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SEA |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SEA |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SEA |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SwissTargetPrediction and SEA |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SEA |
| P21731 | TBXA2R | Thromboxane A2 receptor | T76198 | SEA |
| P18825 | ADRA2C | Adrenergic receptor alpha-2 | T01777 | SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SwissTargetPrediction and SEA |
| P41145 | OPRK1 | Kappa Opioid receptor | T60693 | SEA |
| P10827 | THRA | Thyroid hormone receptor alpha | T79591 | SEA |
| P10828 | THRB | Thyroid hormone receptor beta-1 | T98933 | SEA |
| P52732 | KIF11 | Kinesin-like protein 1 | T28484 | SwissTargetPrediction |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| P04626 | ERBB2 | Receptor protein-tyrosine kinase erbB-2 | T14597 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SEA |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P36888 | FLT3 | Tyrosine-protein kinase receptor FLT3 | T74312 | SwissTargetPrediction |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SwissTargetPrediction |
| Q86V86 | PIM3 | Serine/threonine-protein kinase PIM3 | T16596 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P13497 | BMP1 | Bone morphogenetic protein 1 | T53350 | SEA |
| P25105 | PTAFR | Platelet activating factor receptor | T87023 | SEA |
| P07711 | CTSL | Cathepsin L | T98691 | SEA |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction and SEA |
| P23946 | CMA1 | Chymase | T05114 | SEA |
| P00742 | F10 | Thrombin and coagulation factor X | T84631 | SwissTargetPrediction |
| P62942 | FKBP1A | FK506-binding protein 1A | T76059 | SEA |
| O43193 | MLNR | Motilin receptor | T62306 | SEA |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SEA |
| P43116 | PTGER2 | Prostanoid EP2 receptor | T38529 | SEA |
| Q06124 | PTPN11 | Protein-tyrosine phosphatase 2C | T13057 | SEA |
| Q15722 | LTB4R | Leukotriene B4 receptor 1 | T59626 | SEA |
| P11137 | MAP2 | Microtubule-associated protein 2 | T23276 | SEA |
| P13500 | CCL2 | C-C motif chemokine 2 | T89988 | SEA |
| P35348 | ADRA1A | Alpha-1a adrenergic receptor | T92609 | SEA |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | T06093 | SwissTargetPrediction and SEA |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | T96623 | SwissTargetPrediction |
| P47871 | GCGR | Glucagon receptor | T60182 | SEA |
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | T08123 | SwissTargetPrediction |
| P41229 | KDM5C | Lysine-specific demethylase 5C | T85540 | SwissTargetPrediction |
| P36897 | TGFBR1 | TGF-beta receptor type I | T53389 | SEA |
| O00329 | PIK3CD | PI3-kinase p110-delta subunit | T67849 | SwissTargetPrediction |
| P17948 | FLT1 | Vascular endothelial growth factor receptor 1 | T63966 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction and SEA |
| Q9HBH9 | MKNK2 | MAP kinase signal-integrating kinase 2 | T99160 | SwissTargetPrediction |
| P25098 | GRK2 | G-protein coupled receptor kinase 2 | T62548 | SwissTargetPrediction and SEA |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P33981 | TTK | Dual specificity protein kinase TTK | T74977 | SwissTargetPrediction |
| P49759 | CLK1 | Dual specificty protein kinase CLK1 | T46685 | SwissTargetPrediction and SEA |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| P29597 | TYK2 | Tyrosine-protein kinase TYK2 | T78932 | SwissTargetPrediction |
| Q6P179 | ERAP2 | Endoplasmic reticulum aminopeptidase 2 | T65818 | SEA |
| P20151 | KLK2 | Kallikrein 2 | T01908 | SEA |
| P47898 | HTR5A | Serotonin 5a (5-HT5a) receptor | T15571 | SwissTargetPrediction and SEA |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SEA |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SEA |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SEA |
| P34972 | CNR2 | Cannabinoid receptor 2 | T37693 | SwissTargetPrediction |
| P43115 | PTGER3 | Prostanoid EP3 receptor | T85467 | SEA |
| P06756 | ITGAV | Vitronectin receptor alpha | T67103 | SEA |
| P17301 | ITGA2 | Integrin alpha-2 | T55293 | SEA |
| O00311 | CDC7 | CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) | T81358 | SwissTargetPrediction |
| P42892 | ECE1 | Endothelin-converting enzyme 1 | T50970 | SEA |
| Q9ULW8 | PADI3 | Protein-arginine deiminase type-3 | T36612 | SEA |
| Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | T50429 | SEA |
| Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | T98225 | SEA |
| P11362 | FGFR1 | Fibroblast growth factor receptor 1 | T47101 | SwissTargetPrediction |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SEA |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P49840 | GSK3A | Glycogen synthase kinase-3 alpha | T76910 | SwissTargetPrediction |
| P50750 | CDK9 | Cyclin-dependent kinase 9 | T44458 | SwissTargetPrediction |
| P49761 | CLK3 | Dual specificity protein kinase CLK3 | T21585 | SwissTargetPrediction and SEA |
| P46098 | HTR3A | Serotonin 3a (5-HT3a) receptor | T64591 | SEA |
| Q13258 | PTGDR | Prostanoid DP receptor | T68782 | SEA |
| P17936 | IGFBP3 | Insulin-like growth factor binding protein 3 | T33455 | SEA |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SEA |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P43119 | PTGIR | Prostanoid IP receptor | T99954 | SEA |
| P53350 | PLK1 | Serine/threonine-protein kinase PLK1 | T40694 | SEA |
| P00749 | PLAU | Urokinase-type plasminogen activator | T17758 | SEA |
| P04049 | RAF1 | Serine/threonine-protein kinase RAF | T51883 | SwissTargetPrediction |
| Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | T23787 | SwissTargetPrediction |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | T99089 | SwissTargetPrediction |
| P24530 | EDNRB | Endothelin receptor ET-B | T92828 | SEA |
| Q9Y210 | TRPC6 | Short transient receptor potential channel 6 | T80165 | SwissTargetPrediction |
| P53671 | LIMK2 | LIM domain kinase 2 | T09133 | SEA |
| P50053 | KHK | Ketohexokinase | T79326 | SwissTargetPrediction |
| P43490 | NAMPT | Nicotinamide phosphoribosyltransferase | T54582 | SEA |
| Q14524 | SCN5A | Sodium channel protein type V alpha subunit | T39716 | SEA |
| P22460 | KCNA5 | Voltage-gated potassium channel subunit Kv1.5 | T17569 | SEA |
| Q9UKP6 | UTS2R | Urotensin II receptor | T49072 | SwissTargetPrediction |
| Q13526 | PIN1 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | T16308 | SEA |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SEA |
| P01130 | LDLR | LDL receptor | T94692 | SEA |
| Q92630 | DYRK2 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | T39486 | SwissTargetPrediction and SEA |
| Q15746 | MYLK | Myosin light chain kinase, smooth muscle | T97141 | SwissTargetPrediction |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | T51282 | SwissTargetPrediction and SEA |
| P06730 | EIF4E | Eukaryotic translation initation factor (by homology) | T31186 | SEA |
| Q16548 | BCL2A1 | Bcl-2-related protein A1 (by homology) | T12797 | SEA |
| Q15661 | TPSAB1 | Tryptase beta-1 | T14558 | SEA |
| Q13393 | PLD1 | Phospholipase D1 | T38996 | SEA |
| O14939 | PLD2 | Phospholipase D2 | T10383 | SEA |
| O43497 | CACNA1G | Voltage-gated T-type calcium channel alpha-1G subunit | T64795 | SEA |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| Q13224 | GRIN2B | Glutamate [NMDA] receptor subunit epsilon 2 | T76414 | SEA |
| Q15303 | ERBB4 | Receptor protein-tyrosine kinase erbB-4 | T92057 | SwissTargetPrediction |
| P49682 | CXCR3 | C-X-C chemokine receptor type 3 | T25315 | SEA |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor R1 | T86552 | SEA |
| P28336 | NMBR | Neuromedin B receptor | T68887 | SEA |
| Q9NRG4 | SMYD2 | N-lysine methyltransferase SMYD2 | T15797 | SEA |
| P37840 | SNCA | Alpha-synuclein | T03644 | SEA |
| Q96DB2 | HDAC11 | Histone deacetylase 11 | T97903 | SEA |
| P33032 | MC5R | Melanocortin receptor 5 | T95302 | SEA |
| Q9H1C0 | LPAR5 | Lysophosphatidic acid receptor 5 | T18616 | SEA |
| P09382 | LGALS1 | Galectin-1 | T09544 | SEA |
| Q969S8 | HDAC10 | Histone deacetylase 10 | T94324 | SEA |
| O95136 | S1PR2 | Sphingosine 1-phosphate receptor Edg-5 | T47888 | SEA |
| Q9Y271 | CYSLTR1 | Cysteinyl leukotriene receptor 1 | T71192 | SEA |
| Q9H2K8 | TAOK3 | Serine/threonine-protein kinase TAO3 | T63682 | SEA |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| Q9UJ67 | APAF1 | Caterpiller protein 1.1 | T08499 | SEA |
| Q9Y345 | SLC6A5 | Glycine transporter 2 | T58937 | SwissTargetPrediction and SEA |
| Q92633 | LPAR1 | Lysophosphatidic acid receptor Edg-2 | T92640 | SEA |
| P16885 | PLCG2 | Phospholipase C-gamma-2 | T93922 | SEA |
| Q6DWJ6 | GPR139 | Probable G-protein coupled receptor 139 | T84439 | SEA |
| P40306 | PSMB10 | 26S proteosome | T09022 | SEA |
| P08311 | CTSG | Cathepsin G | T86385 | SEA |
| P04792 | HSPB1 | Heat shock protein beta-1 | T39921 | SEA |
| Q9UJM8 | HAO1 | Hydroxyacid oxidase 1 | T63170 | SEA |
| Q9P0U3 | SENP1 | Sentrin-specific protease 1 | T96435 | SEA |
| O95822 | MLYCD | Malonyl-CoA decarboxylase | T98078 | SEA |
| P01275 | GCG | Glucagon | T44919 | SEA |
| P48546 | GIPR | Gastric inhibitory polypeptide receptor | T41750 | SEA |
| Q8IWU9 | TPH2 | Tryptophan hydroxylase | T51593 | SEA |
| P13500 | CCL2 | C-C motif chemokine 2 | T89988 | SEA |
| P24557 | TBXAS1 | Thromboxane-A synthase | T78356 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P09958 | FUR | HUMAN dibasic-processing enzyme | T98945 | SEA |
| Q9GZQ6 | NPFFR1 | Neuropeptide FF receptor 1 | T79780 | SEA |
| Q9Y5X5 | NPFFR2 | Neuropeptide FF receptor 2 | T90818 | SEA |
| O60259 | KLK8 | Neuropsin | T43289 | SEA |
| Q9BY41 | HDAC8 | Histone deacetylase 8 | T28887 | SEA |
| Q9Y5K2 | KLK4 | Kallikrein-4 | T79400 | SEA |
| P51843 | NR0B1 | Orphan nuclear receptor DAX-1 | T23191 | SEA |
| Q7RTX1 | TAS1R1 | Taste receptor | T41263 | SEA |
| P05106 | ITGB3 | Integrin beta-3 | T26457 | SEA |
| P55011 | SLC12A2 | Na-K-Cl cotransporter | T85581 | SEA |
| Q9HAN5 | TRP1 | Cationic trypsinogen | T27602 | SEA |
| P35270 | SPR | Substance-P receptor | T47094 | SEA |
| P25786 | PSMA1 | Core proteasome 20S complex | T61997 | SEA |
| P28072 | PSMB6 | Proteasome beta-1 | T54973 | SEA |
| Q99436 | PSMB7 | Proteasome beta-2 | T55986 | SEA |
| P43354 | NR4A2 | Orphan nuclear receptor NURR1 | T67163 | SEA |
| Q4ZFZ2 | FSHR | Follicle-stimulating hormone receptor | T68334 | SEA |
| Q96LD8 | SENP8 | Deneddylase-1 | T13928 | SEA |
| P41587 | VIPR2 | Helodermin-preferring VIP receptor | T06182 | SEA |
| P18564 | ITGB6 | Integrin beta-6 | T23178 | SEA |
| Q9GZT9 | EGLN1 | Egl nine homolog 1 | T32880 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T79961 | DI0002 | Abnormal micturition | [ICD-11: MF50] | P08912 | CHRM5 |
| T79961 | DI0032 | Anterior uveitis | [ICD-11: 9A96] | P08912 | CHRM5 |
| T79961 | DI0034 | Appearance/behaviour symptom | [ICD-11: MB23] | P08912 | CHRM5 |
| T79961 | DI0037 | Asthma | [ICD-11: CA23] | P08912 | CHRM5 |
| T79961 | DI0061 | Brain disease | [ICD-11: 8C70-8E61] | P08912 | CHRM5 |
| T79961 | DI0071 | Central and peripheral nervous disease | [ICD-11: 8A04-8E7Z] | P08912 | CHRM5 |
| T79961 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P08912 | CHRM5 |
| T79961 | DI0093 | Cognition symptoms/signs/clinical symptom | [ICD-11: MB21] | P08912 | CHRM5 |
| T79961 | DI0105 | Cough | [ICD-11: MD12] | P08912 | CHRM5 |
| T79961 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P08912 | CHRM5 |
| T79961 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P08912 | CHRM5 |
| T79961 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P08912 | CHRM5 |
| T79961 | DI0158 | Gastritis | [ICD-11: DA42] | P08912 | CHRM5 |
| T79961 | DI0162 | General examination | [ICD-11: QA00] | P08912 | CHRM5 |
| T79961 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08912 | CHRM5 |
| T79961 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08912 | CHRM5 |
| T79961 | DI0208 | Infectious gastroenteritis/colitis | [ICD-11: 1A40] | P08912 | CHRM5 |
| T79961 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P08912 | CHRM5 |
| T79961 | DI0307 | Nystagmus | [ICD-11: 9C84] | P08912 | CHRM5 |
| T79961 | DI0315 | Oesophagus motility disorder | [ICD-11: DA21] | P08912 | CHRM5 |
| T79961 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P08912 | CHRM5 |
| T79961 | DI0329 | Pancreatitis | [ICD-11: DC31-DC34] | P08912 | CHRM5 |
| T79961 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P08912 | CHRM5 |
| T79961 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08912 | CHRM5 |
| T79961 | DI0338 | Polyuria | [ICD-11: MF55] | P08912 | CHRM5 |
| T79961 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P08912 | CHRM5 |
| T79961 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P08912 | CHRM5 |
| T79961 | DI0424 | Urgency | [ICD-11: N.A.] | P08912 | CHRM5 |
| T28893 | DI0001 | Abdominal pelvic pain | [ICD-11: MD81] | P11229 | CHRM1 |
| T28893 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11229 | CHRM1 |
| T28893 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P11229 | CHRM1 |
| T28893 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P11229 | CHRM1 |
| T28893 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P11229 | CHRM1 |
| T28893 | DI0157 | Gastric ulcer | [ICD-11: DA60] | P11229 | CHRM1 |
| T28893 | DI0166 | Glaucoma | [ICD-11: 9C61] | P11229 | CHRM1 |
| T28893 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P11229 | CHRM1 |
| T28893 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P11229 | CHRM1 |
| T28893 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P11229 | CHRM1 |
| T28893 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P11229 | CHRM1 |
| T28893 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P11229 | CHRM1 |
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T67684 | DI0037 | Asthma | [ICD-11: CA23] | P20309 | CHRM3 |
| T67684 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P20309 | CHRM3 |
| T67684 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P20309 | CHRM3 |
| T67684 | DI0166 | Glaucoma | [ICD-11: 9C61] | P20309 | CHRM3 |
| T67684 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P20309 | CHRM3 |
| T67684 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P20309 | CHRM3 |
| T67684 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P20309 | CHRM3 |
| T67684 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P20309 | CHRM3 |
| T67684 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P20309 | CHRM3 |
| T67684 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P20309 | CHRM3 |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T16117 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P29475 | NOS1 |
| T16117 | DI0264 | Migraine | [ICD-11: 8A80] | P29475 | NOS1 |
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T06046 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P29474 | NOS3 |
| T14912 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q07820 | MCL1 |
| T14912 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q07820 | MCL1 |
| T14912 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q07820 | MCL1 |
| T14912 | DI0252 | Melanoma | [ICD-11: 2C30] | Q07820 | MCL1 |
| T14912 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q07820 | MCL1 |
| T14912 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q07820 | MCL1 |
| T46360 | DI0105 | Cough | [ICD-11: MD12] | Q99720 | SIGMAR1 |
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T53904 | DI0010 | Acute disease anaemia | [ICD-11: 3A90] | Q96KS0 | EIT6 |
| T67272 | DI0351 | Psoriasis | [ICD-11: EA90] | P15144 | ANPEP |
| T94033 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00734 | F2 |
| T94033 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00734 | F2 |
| T94033 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P00734 | F2 |
| T94033 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P00734 | F2 |
| T94033 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00734 | F2 |
| T94033 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00734 | F2 |
| T94033 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P00734 | F2 |
| T94033 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00734 | F2 |
| T05090 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O15379 | HDAC3 |
| T05090 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15379 | HDAC3 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T75498 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P16083 | NQO2 |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T83904 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q8IXJ6 | SIRT2 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T50688 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P08514 | ITGA2B |
| T50688 | DI0030 | Angina pectoris | [ICD-11: BA40] | P08514 | ITGA2B |
| T50688 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08514 | ITGA2B |
| T51426 | DI0043 | Autoimmune liver disease | [ICD-11: DB96] | Q96RI1 | NR1H4 |
| T51426 | DI0077 | Cholelithiasis | [ICD-11: DC11] | Q96RI1 | NR1H4 |
| T51426 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q96RI1 | NR1H4 |
| T05409 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08473 | MME |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T76685 | DI0031 | Anorexia nervosa | [ICD-11: 6B80] | P21554 | CNR1 |
| T76685 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P21554 | CNR1 |
| T76685 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P21554 | CNR1 |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T16739 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O60341 | KDM1A |
| T16739 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O60341 | KDM1A |
| T16739 | DI0138 | Ewing sarcoma | [ICD-11: 2B52] | O60341 | KDM1A |
| T16739 | DI0238 | Lung cancer | [ICD-11: 2C25] | O60341 | KDM1A |
| T16739 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O60341 | KDM1A |
| T16739 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O60341 | KDM1A |
| T16739 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O60341 | KDM1A |
| T16739 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60341 | KDM1A |
| T16739 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O60341 | KDM1A |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T55959 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q01959 | SLC6A3 |
| T55959 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q01959 | SLC6A3 |
| T55959 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q01959 | SLC6A3 |
| T55959 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q01959 | SLC6A3 |
| T55959 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q01959 | SLC6A3 |
| T55959 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q01959 | SLC6A3 |
| T63816 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P56524 | HDAC4 |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T09572 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q99705 | MCHR1 |
| T76369 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P23141 | CES1 |
| T76369 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P23141 | CES1 |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T22939 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06401 | PGR |
| T22939 | DI0100 | Contraceptive management | [ICD-11: QA21] | P06401 | PGR |
| T22939 | DI0255 | Menstrual cycle bleeding disorder | [ICD-11: GA20] | P06401 | PGR |
| T22939 | DI0344 | Preterm labour/delivery | [ICD-11: JB00] | P06401 | PGR |
| T22939 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06401 | PGR |
| T30985 | DI0161 | Gastro-oesophageal reflux disease | [ICD-11: DA22] | P25021 | HRH2 |
| T30985 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P25021 | HRH2 |
| T30985 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P25021 | HRH2 |
| T43115 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P08575 | PTPRC |
| T43115 | DI0414 | Transplanted organ/tissue | [ICD-11: QB63] | P08575 | PTPRC |
| T21307 | DI0011 | Acute laryngitis/tracheitis | [ICD-11: CA05] | P49137 | MAPKAPK2 |
| T21307 | DI0181 | Hidradenitis suppurativa | [ICD-11: ED92] | P49137 | MAPKAPK2 |
| T21307 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P49137 | MAPKAPK2 |
| T21307 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P49137 | MAPKAPK2 |
| T21307 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P49137 | MAPKAPK2 |
| T21307 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P49137 | MAPKAPK2 |
| T21307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49137 | MAPKAPK2 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T76198 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P21731 | TBXA2R |
| T76198 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P21731 | TBXA2R |
| T76198 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P21731 | TBXA2R |
| T76198 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P21731 | TBXA2R |
| T01777 | DI0166 | Glaucoma | [ICD-11: 9C61] | P18825 | ADRA2C |
| T01777 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P18825 | ADRA2C |
| T01777 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P18825 | ADRA2C |
| T01777 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18825 | ADRA2C |
| T01777 | DI0310 | Ocular disease | [ICD-11: N.A.] | P18825 | ADRA2C |
| T01777 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18825 | ADRA2C |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T60693 | DI0304 | Non-specific cutaneous vascular symptom | [ICD-11: ME64] | P41145 | OPRK1 |
| T60693 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41145 | OPRK1 |
| T60693 | DI0349 | Pruritus | [ICD-11: EC90] | P41145 | OPRK1 |
| T79591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10827 | THRA |
| T79591 | DI0197 | Hypo-thyroidism | [ICD-11: 5A00] | P10827 | THRA |
| T98933 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10828 | THRB |
| T28484 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P52732 | KIF11 |
| T28484 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | P52732 | KIF11 |
| T28484 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P52732 | KIF11 |
| T28484 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P52732 | KIF11 |
| T28484 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P52732 | KIF11 |
| T28484 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P52732 | KIF11 |
| T28484 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P52732 | KIF11 |
| T28484 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P52732 | KIF11 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T14597 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P04626 | ERBB2 |
| T14597 | DI0238 | Lung cancer | [ICD-11: 2C25] | P04626 | ERBB2 |
| T14597 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P04626 | ERBB2 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T74312 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P36888 | FLT3 |
| T74312 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P36888 | FLT3 |
| T74312 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P36888 | FLT3 |
| T74312 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P36888 | FLT3 |
| T74312 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P36888 | FLT3 |
| T74312 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P36888 | FLT3 |
| T74312 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P36888 | FLT3 |
| T74312 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P36888 | FLT3 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T87023 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P25105 | PTAFR |
| T98691 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P07711 | CTSL |
| T98691 | DI0376 | Severe acute respiratory syndrome | [ICD-11: 1D65] | P07711 | CTSL |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T05114 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23946 | CMA1 |
| T05114 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P23946 | CMA1 |
| T05114 | DI0169 | Gram-positive bacterial infection | [ICD-11: 1B74-1F40] | P23946 | CMA1 |
| T05114 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P23946 | CMA1 |
| T05114 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P23946 | CMA1 |
| T05114 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P23946 | CMA1 |
| T84631 | DI0053 | Blood-forming organ disease | [ICD-11: 3C0Z] | P00742 | F10 |
| T84631 | DI0080 | Christmas disease | [ICD-11: 3B11] | P00742 | F10 |
| T84631 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00742 | F10 |
| T84631 | DI0103 | Coronary thrombosis | [ICD-11: BA43] | P00742 | F10 |
| T84631 | DI0114 | Deep vein thrombosis | [ICD-11: BD71] | P00742 | F10 |
| T84631 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P00742 | F10 |
| T84631 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00742 | F10 |
| T84631 | DI0433 | Venous thromboembolism | [ICD-11: BD72] | P00742 | F10 |
| T76059 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P62942 | FKBP1A |
| T76059 | DI0349 | Pruritus | [ICD-11: EC90] | P62942 | FKBP1A |
| T76059 | DI0413 | Transplant rejection | [ICD-11: NE84] | P62942 | FKBP1A |
| T62306 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | O43193 | MLNR |
| T62306 | DI0159 | Gastroduodenal motor/secretory disorder | [ICD-11: DA41] | O43193 | MLNR |
| T62306 | DI0161 | Gastro-oesophageal reflux disease | [ICD-11: DA22] | O43193 | MLNR |
| T62306 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O43193 | MLNR |
| T62306 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | O43193 | MLNR |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T38529 | DI0003 | Abortion | [ICD-11: JA00] | P43116 | PTGER2 |
| T38529 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P43116 | PTGER2 |
| T38529 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P43116 | PTGER2 |
| T38529 | DI0166 | Glaucoma | [ICD-11: 9C61] | P43116 | PTGER2 |
| T38529 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P43116 | PTGER2 |
| T38529 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P43116 | PTGER2 |
| T38529 | DI0413 | Transplant rejection | [ICD-11: NE84] | P43116 | PTGER2 |
| T13057 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q06124 | PTPN11 |
| T59626 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | Q15722 | LTB4R |
| T59626 | DI0355 | Pulmonary disease | [ICD-11: 1B10-1F85] | Q15722 | LTB4R |
| T59626 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | Q15722 | LTB4R |
| T23276 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P11137 | MAP2 |
| T23276 | DI0252 | Melanoma | [ICD-11: 2C30] | P11137 | MAP2 |
| T23276 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P11137 | MAP2 |
| T23276 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11137 | MAP2 |
| T89988 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P13500 | CCL2 |
| T89988 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P13500 | CCL2 |
| T89988 | DI0087 | Chronic pain | [ICD-11: MG30] | P13500 | CCL2 |
| T89988 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P13500 | CCL2 |
| T89988 | DI0252 | Melanoma | [ICD-11: 2C30] | P13500 | CCL2 |
| T89988 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P13500 | CCL2 |
| T89988 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P13500 | CCL2 |
| T89988 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P13500 | CCL2 |
| T89988 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P13500 | CCL2 |
| T89988 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P13500 | CCL2 |
| T92609 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35348 | ADRA1A |
| T92609 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P35348 | ADRA1A |
| T06093 | DI0168 | Graft-versus-host disease | [ICD-11: 4B24] | O75116 | ROCK2 |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T96623 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P08238 | HSP90AB1 |
| T96623 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08238 | HSP90AB1 |
| T96623 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P08238 | HSP90AB1 |
| T96623 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P08238 | HSP90AB1 |
| T96623 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P08238 | HSP90AB1 |
| T96623 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P08238 | HSP90AB1 |
| T96623 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P08238 | HSP90AB1 |
| T60182 | DI0193 | Hypo-glycaemia | [ICD-11: 5A41] | P47871 | GCGR |
| T08123 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q5S007 | LRRK2 |
| T53389 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P36897 | TGFBR1 |
| T53389 | DI0238 | Lung cancer | [ICD-11: 2C25] | P36897 | TGFBR1 |
| T67849 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | O00329 | PIK3CD |
| T67849 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00329 | PIK3CD |
| T67849 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | O00329 | PIK3CD |
| T67849 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | O00329 | PIK3CD |
| T67849 | DI0395 | Stomach cancer | [ICD-11: 2B72] | O00329 | PIK3CD |
| T63966 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P17948 | FLT1 |
| T99160 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9HBH9 | MKNK2 |
| T99160 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9HBH9 | MKNK2 |
| T99160 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q9HBH9 | MKNK2 |
| T99160 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9HBH9 | MKNK2 |
| T99160 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9HBH9 | MKNK2 |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T74977 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P33981 | TTK |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T78932 | DI0351 | Psoriasis | [ICD-11: EA90] | P29597 | TYK2 |
| T01908 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P20151 | KLK2 |
| T15571 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P47898 | HTR5A |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T37693 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34972 | CNR2 |
| T37693 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P34972 | CNR2 |
| T85467 | DI0166 | Glaucoma | [ICD-11: 9C61] | P43115 | PTGER3 |
| T85467 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P43115 | PTGER3 |
| T85467 | DI0414 | Transplanted organ/tissue | [ICD-11: QB63] | P43115 | PTGER3 |
| T67103 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P06756 | ITGAV |
| T67103 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06756 | ITGAV |
| T55293 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P17301 | ITGA2 |
| T55293 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P17301 | ITGA2 |
| T81358 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00311 | CDC7 |
| T81358 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O00311 | CDC7 |
| T47101 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11362 | FGFR1 |
| T47101 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P11362 | FGFR1 |
| T47101 | DI0235 | Liver cancer | [ICD-11: 2C12] | P11362 | FGFR1 |
| T47101 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P11362 | FGFR1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T76910 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P49840 | GSK3A |
| T44458 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P50750 | CDK9 |
| T44458 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P50750 | CDK9 |
| T44458 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50750 | CDK9 |
| T44458 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P50750 | CDK9 |
| T44458 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P50750 | CDK9 |
| T44458 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P50750 | CDK9 |
| T44458 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50750 | CDK9 |
| T64591 | DI0087 | Chronic pain | [ICD-11: MG30] | P46098 | HTR3A |
| T64591 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P46098 | HTR3A |
| T64591 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P46098 | HTR3A |
| T64591 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P46098 | HTR3A |
| T64591 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P46098 | HTR3A |
| T68782 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q13258 | PTGDR |
| T33455 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P17936 | IGFBP3 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T99954 | DI0003 | Abortion | [ICD-11: JA00] | P43119 | PTGIR |
| T99954 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P43119 | PTGIR |
| T99954 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P43119 | PTGIR |
| T40694 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P53350 | PLK1 |
| T40694 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P53350 | PLK1 |
| T40694 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P53350 | PLK1 |
| T17758 | DI0211 | Inherited coagulation factor deficiency | [ICD-11: 3B14] | P00749 | PLAU |
| T17758 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00749 | PLAU |
| T51883 | DI0252 | Melanoma | [ICD-11: 2C30] | P04049 | RAF1 |
| T51883 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04049 | RAF1 |
| T51883 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P04049 | RAF1 |
| T51883 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04049 | RAF1 |
| T23787 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16875 | PFKFB3 |
| T99089 | DI0252 | Melanoma | [ICD-11: 2C30] | P15056 | BRAF |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |
| T54582 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P43490 | NAMPT |
| T54582 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P43490 | NAMPT |
| T54582 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P43490 | NAMPT |
| T39716 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q14524 | SCN5A |
| T39716 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | Q14524 | SCN5A |
| T39716 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q14524 | SCN5A |
| T39716 | DI0105 | Cough | [ICD-11: MD12] | Q14524 | SCN5A |
| T39716 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | Q14524 | SCN5A |
| T39716 | DI0264 | Migraine | [ICD-11: 8A80] | Q14524 | SCN5A |
| T39716 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q14524 | SCN5A |
| T39716 | DI0434 | Ventricular tachyarrhythmia | [ICD-11: BC71] | Q14524 | SCN5A |
| T17569 | DI0030 | Angina pectoris | [ICD-11: BA40] | P22460 | KCNA5 |
| T49072 | DI0037 | Asthma | [ICD-11: CA23] | Q9UKP6 | UTS2R |
| T16308 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q13526 | PIN1 |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T94692 | DI0238 | Lung cancer | [ICD-11: 2C25] | P01130 | LDLR |
| T97141 | DI0127 | Duodenal ulcer | [ICD-11: DA63] | Q15746 | MYLK |
| T51282 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q13464 | ROCK1 |
| T14558 | DI0155 | Fungal infection | [ICD-11: 1F29-1F2F] | Q15661 | TPSAB1 |
| T14558 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q15661 | TPSAB1 |
| T10383 | DI0091 | Coagulation defect | [ICD-11: 3B10] | O14939 | PLD2 |
| T64795 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O43497 | CACNA1G |
| T64795 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O43497 | CACNA1G |
| T64795 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | O43497 | CACNA1G |
| T64795 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O43497 | CACNA1G |
| T64795 | DI0370 | Schizophrenia | [ICD-11: 6A20] | O43497 | CACNA1G |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T76414 | DI0024 | Alpha-1-antitrypsin deficiency | [ICD-11: 5C5A] | Q13224 | GRIN2B |
| T92057 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q15303 | ERBB4 |
| T25315 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P49682 | CXCR3 |
| T25315 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P49682 | CXCR3 |
| T25315 | DI0351 | Psoriasis | [ICD-11: EA90] | P49682 | CXCR3 |
| T25315 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49682 | CXCR3 |
| T86552 | DI0060 | Brain cancer | [ICD-11: 2A00] | P19438 | TNFRSF1A |
| T86552 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P19438 | TNFRSF1A |
| T68887 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P28336 | NMBR |
| T68887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28336 | NMBR |
| T15797 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q9NRG4 | SMYD2 |
| T15797 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NRG4 | SMYD2 |
| T03644 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P37840 | SNCA |
| T03644 | DI0044 | Autonomic nervous system disorder | [ICD-11: 8D87] | P37840 | SNCA |
| T03644 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P37840 | SNCA |
| T95302 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P33032 | MC5R |
| T95302 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P33032 | MC5R |
| T94324 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q969S8 | HDAC10 |
| T47888 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | O95136 | S1PR2 |
| T71192 | DI0037 | Asthma | [ICD-11: CA23] | Q9Y271 | CYSLTR1 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T08499 | DI0087 | Chronic pain | [ICD-11: MG30] | Q9UJ67 | APAF1 |
| T08499 | DI0167 | Gout | [ICD-11: FA25] | Q9UJ67 | APAF1 |
| T08499 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9UJ67 | APAF1 |
| T08499 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UJ67 | APAF1 |
| T92640 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q92633 | LPAR1 |
| T92640 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q92633 | LPAR1 |
| T92640 | DI0351 | Psoriasis | [ICD-11: EA90] | Q92633 | LPAR1 |
| T92640 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q92633 | LPAR1 |
| T84439 | DI0377 | Sex development malformative disorder | [ICD-11: LD2A] | Q6DWJ6 | GPR139 |
| T86385 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P08311 | CTSG |
| T39921 | DI0037 | Asthma | [ICD-11: CA23] | P04792 | HSPB1 |
| T63170 | DI0201 | Inborn carbohydrate metabolism error | [ICD-11: 5C51] | Q9UJM8 | HAO1 |
| T44919 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P01275 | GCG |
| T44919 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P01275 | GCG |
| T44919 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P01275 | GCG |
| T44919 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P01275 | GCG |
| T44919 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P01275 | GCG |
| T41750 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P48546 | GIPR |
| T51593 | DI0066 | Carcinoid syndrome | [ICD-11: 5B10] | Q8IWU9 | TPH2 |
| T51593 | DI0389 | Small intestine developmental anomaly | [ICD-11: DA90] | Q8IWU9 | TPH2 |
| T89988 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P13500 | CCL2 |
| T89988 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P13500 | CCL2 |
| T89988 | DI0087 | Chronic pain | [ICD-11: MG30] | P13500 | CCL2 |
| T89988 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P13500 | CCL2 |
| T89988 | DI0252 | Melanoma | [ICD-11: 2C30] | P13500 | CCL2 |
| T89988 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P13500 | CCL2 |
| T89988 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P13500 | CCL2 |
| T89988 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P13500 | CCL2 |
| T89988 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P13500 | CCL2 |
| T89988 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P13500 | CCL2 |
| T78356 | DI0030 | Angina pectoris | [ICD-11: BA40] | P24557 | TBXAS1 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T98945 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P09958 | FUR |
| T28887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BY41 | HDAC8 |
| T41263 | DI0078 | Cholera | [ICD-11: 1A00] | Q7RTX1 | TAS1R1 |
| T85581 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P55011 | SLC12A2 |
| T27602 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q9HAN5 | TRP1 |
| T27602 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9HAN5 | TRP1 |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T68334 | DI0144 | Female infertility | [ICD-11: GA31] | Q4ZFZ2 | FSHR |
| T06182 | DI0069 | Cardiomyopathy | [ICD-11: BC43] | P41587 | VIPR2 |
| T06182 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P41587 | VIPR2 |
| T06182 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P41587 | VIPR2 |
| T06182 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P41587 | VIPR2 |
| T06182 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P41587 | VIPR2 |
| T06182 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P41587 | VIPR2 |
| T23178 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P18564 | ITGB6 |